EML-2949

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEML-2949
Drug Alias NameEML-2949EMD-392949
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A